Speeple News Search

Sign Up! | Tags | Domains | Statistics | Options | Advanced Search

Imclone Really Does Get Bought

corante.com » 2008 » October » 6th » Imclone Really Does Get Bought

Tagged: business and markets

Well, it looks as if I'll finally be able to stop talking about Imclone: the word came out this morning that they've agreed to a $70/share deal with Lilly. Some thoughts on this: 1. I would still like to know how the uncertainty around the Erbitux follow-up antibody is supposed to be resolved. It's hard for me to make sense of this for Lilly unless they think that they can get substantial … Continue Reading »

Latest news from In the Pipeline:

  1. Torcetrapib: What Was the Problem? And Does It Matter?
  2. Prodrugs: How the Pros Do It?
  3. How Slow is Research Today? Here's a Recipe!
  4. Avandia: Trouble, Run Head to Head
  5. Two Drugs in One? Maybe Not.

Latest news from corante.com:

  1. Continuing on the Morality Theme
  2. BadOnlineDates.com Introduces Virtual Dating
  3. Match.com Redesign and New Features and UK Personality Testing
  4. Are You Interested Starts Sharing
  5. Global Neurosecurity Discussions Needed